400-921-8278
| Catalog_no | ADMC0956 |
| Product_name | Delanzomib(CEP-18770) |
| Category | 抑制剂与激动剂 |
| Size | 10mg/50mg/100mg |
| Price | 2560.00/7220.00/10660.00 |
| Specificity | Target: Proteasome . Fields: Delanzomib(CEP-18770) is a novel orally-active inhibitor of the chymotrypsin-like activity of the proteasome that down-modulates the nuclear factor-kappaB (NF-kappaB) activity. |
| Purification | >98% |
| Concentration | 靶点：Proteasome;IC50：No data |
| Storage_stability | 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
| othername | CEP-18770,CEP 18770,CEP18770 |
| Observed_band | 413.28 |
| Notes | Delanzomib(CEP-18770) is a novel orally-active inhibitor of the chymotrypsin-like activity of the proteasome that down-modulates the nuclear factor-kappaB (NF-kappaB) activity. |
| Instructions | 
查看与下载 |
| Share |
 |
Copyright © 2021 苏州博特龙免疫技术有限公司 版权所有 ，苏ICP备2021013855号-1
苏公网安备32050702011981号 
